Cargando…
Prophylactic and Therapeutic EBV Vaccines: Major Scientific Obstacles, Historical Progress, and Future Direction
The Epstein-Barr virus (EBV) infects more than 95% of adults worldwide and is associated with various malignant tumors and immune diseases, imparting a huge disease burden on the human population. Available EBV vaccines are imminent. Prophylactic vaccines can effectively prevent the spread of infect...
Autores principales: | Cai, Jing, Zhang, Bodou, Li, Yuqi, Zhu, Wanfang, Akihisa, Toshihiro, Li, Wei, Kikuchi, Takashi, Liu, Wenyuan, Feng, Feng, Zhang, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623587/ https://www.ncbi.nlm.nih.gov/pubmed/34835222 http://dx.doi.org/10.3390/vaccines9111290 |
Ejemplares similares
-
Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective
por: Escalante, Gabriela M., et al.
Publicado: (2022) -
Major Scientific Hurdles in HIV Vaccine Development: Historical Perspective and Future Directions
por: Ng’uni, Tiza, et al.
Publicado: (2020) -
Progress in Prophylactic and Therapeutic EBV Vaccine Development Based on Molecular Characteristics of EBV Target Antigens
por: Rozman, Marija, et al.
Publicado: (2022) -
Three new cardiac glycosides obtained from the roots of Streblus asper Lour. and their cytotoxic and melanogenesis-inhibitory activities
por: Miao, Dan, et al.
Publicado: (2018) -
Mendelian randomisation identifies priority groups for prophylactic EBV vaccination
por: Muckian, Marisa D., et al.
Publicado: (2023)